LPAAT-ε Polyclonal Antibody

Rabbit Anti-LPAAT-ε Polyclonal Antibody

Product Specifications

Background

AGPAT5 (1-acylglycerol-3-phosphate O-acyltransferase 5) encodes a member of the 1-acylglycerol-3-phosphate O-acyltransferase family. This integral membrane protein converts lysophosphatidic acid to phosphatidic acid, the second step in de novo phospholipid biosynthesis. A pseudogene of AGPAT5 is present on the Y chromosome.

CAS Number

9007-83-4

Product Name Alternative

AGPAT5; 1-acyl-sn-glycerol-3-phosphate acyltransferase epsilon; 1-acylglycerol-3-phosphate O-acyltransferase 5; 1-AGP acyltransferase 5; 1-AGPAT 5; Lysophosphatidic acid acyltransferase epsilon; LPAAT-epsilon

Gene ID

55326

Accession Number

Q9NUQ2

Reactivity

Human, Mouse

Immunogen

Synthesized peptide derived from the Internal region of human LPAAT-ε at AA range: 210-290

Clonality

Polyclonal

Tag

1-acyl-sn-glycerol-3-phosphate acyltransferase epsilon

Applications

WB, IHC

Purification Method

The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.

Concentration

1 mg/ml

Molecular Weight

45kD

Precautions

The product listed herein is for research use only and is not intended for use in human or clinical diagnosis. Suggested applications of our products are not recommendations to use our products in violation of any patent or as a license. We cannot be responsible for patent infringements or other violations that may occur with the use of this product.

Shipping Conditions

Gel pack with blue ice.

Storage Conditions

Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.

Notes

LPAAT-ε Polyclonal Antibody detects endogenous levels of LPAAT-ε protein.

Observed Molecular Weight

Formulation

Liquid solution

Buffer pH

Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.

Applications Notes

Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: WB 1:500-2000; IHC 1:50-300